Table 1.
Baseline demographics, comorbidities, and characteristic of included studies in the meta-analysis.
| Variable | Stefanini et al. | Bangalore et al. | Hamadeh et al. | Popovic et al | Choudhary et al | Naderi et al | Sang et al. | Kaur et al. | Moretti et al. | Camarero et al. | Wong et al. | Saririan et al. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample (n) | 28 | 18 | 78 | 11 | 39 | 2 | 2 | 4 | 2 | 10 | 3 | 3 |
| Age, y(Mean) | 68 | 63.25 | 64.75 | 63.6 | 61.7 | 58 | 53 | 60.25 | 68.5 | 67.5 | 41.33 | 63 |
| Male, n | 20 | 15 | 49 | 7 | 33 | 2 | 2 | 4 | 1 | 8 | 3 | 1 |
| COVID-19 Test | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR |
| Comorbidities | ||||||||||||
| HTN, n | 20 | 11 | 57 | 5 | 28 | 2 | 1 | 1 | 2 | 7 | – | 3 |
| HLD, n | 12 | 7 | 72 | 4 | 24 | – | – | – | 1 | 7 | – | – |
| DM, n | 9 | 6 | 21 | 8 | 18 | – | – | 2 | – | 1 | – | 1 |
| Symptoms | ||||||||||||
| Chest Pain, n | 22 | 6 | – | – | – | 2 | 1 | 3 | 2 | – | 2 | 1 |
| Fever, n | – | 13 | – | – | – | 2 | 1 | 4 | – | 7 | – | 1 |
| Dyspnea, n | 19 | 15 | – | – | – | 2 | 1 | 4 | 1 | 8 | – | 1 |
| Localization of MI and Type | ||||||||||||
| Anterior, n | 4 | 3 | – | – | 24 | 1 | – | – | 1 | – | 3 | 1 |
| Inferior, n | 11 | 8 | – | – | 11 | – | 1 | – | 1 | – | – | – |
| Lateral, n | 1 | 9 | – | – | 3 | – | – | – | – | – | – | – |
| Obstructive, n | 17 | 8 | 18 | 11 | 33 | 2 | 1 | – | 0 | 9 | 3 | 0 |
| Non-Obstructive, n | 11 | 10 | – | – | – | – | 1 | – | 2 | – | 0 | 3 |
| Outcomes | ||||||||||||
| Alive, n | 16 | – | – | – | – | 2 | 2 | 1 | 1 | 5 | 3 | 1 |
| Dead, n | 11 | 13 | 9 | 3 | 7 | – | 0 | 3 | 1 | 3 | 0 | 2 |